MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2021-22)
- Udyam number
- UDYAM-TS-20-0024034
Usk Therapeutics Private Limited
Usk Therapeutics Private Limited - pharma in Kadugodi, Karnataka, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹2.22 Cr
▲ 14% YoY
Net loss · FY 2025
₹98.93 Lakh
Net margin -44.6%
EBITDA · FY 2025
-₹97.46 Lakh
EBITDA margin -44%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹10 Lakh
Issued & subscribed
Company age
5 yrs
Est. 2021
Employees · EPFO
15
Provident fund records
Directors on board
5
As per MCA filings
About Usk Therapeutics Private Limited
Data last updated:
Usk Therapeutics Private Limited is a private limited company based in Kadugodi, Karnataka, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 27 September 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Bangalore, under CIN U24290KA2021PTC152293. Its GSTIN is 36AACCU9281E1Z4 (Telangana). The company holds 2 GST registrations, all of them active.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹10 Lakh. It is led by directors including Sadu Kameswari (Managing Director) and Sobha Velamuru.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Flat No 102 1st Floor Sv Elegant Syno.2/1 & 2/7 Kumbena Agrahara Belathur, Kadugodi, Karnataka, India – 560067.
As per the financials filed for FY 2025, the company reported a revenue of ₹2.22 Cr, a growth of 14% compared to the previous year. For the same year it recorded a net loss of ₹98.93 Lakh (net margin -44.6%) and EBITDA of -₹97.46 Lakh (EBITDA margin -44%).
The company has about 15 employees on its provident fund (EPFO) records.
Usk Therapeutics Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-TS-20-0024034).
Company details
CIN U24290KA2021PTC152293
Registration Number 152293
Incorporation Date 27 September 2021
ROC Bangalore
Listing Status Unlisted
Company Status Active
MSME Classification Micro
Udyam Registration UDYAM-TS-20-0024034
Recognitions & Rankings of Usk Therapeutics
Contact details
Usk Therapeutics Private Limited's registered office is in Kadugodi, Karnataka. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressFlat No 102 1st Floor Sv Elegant Syno.2/1 & 2/7 Kumbena Agrahara Belathur, Kadugodi, Karnataka, India – 560067
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Usk Therapeutics Private Limited, buy the company report.
Comprehensive company report
Usk Therapeutics Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Usk Therapeutics is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Usk Therapeutics Private Limited, buy the company report.
Financials of Usk Therapeutics Private Limited
FY 2025 filings availableUsk Therapeutics Private Limited reported revenue of ₹2.22 Cr (up 14% YoY) for FY 2025.
Revenue · FY 2025
₹2.22 Cr ▲ 14%
Net loss · FY 2025
₹98.93 Lakh margin -44.6%
EBITDA · FY 2025
-₹97.46 Lakh margin -44%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 14%
EBITDA CAGR growth
1 year
▼ 43%
3 years · compounded
▼ 146%
Revenue rose 14% in the latest year. EBITDA fell 43% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | -₹97.46 Lakh | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | -₹98.93 Lakh | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | -44% | |||
| Net Profit Margin | -44.6% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Usk Therapeutics Private Limited, buy the company report.
Board of directors of Usk Therapeutics Private Limited
Usk Therapeutics has 5 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sadu Kameswari Also directs: K K Reddy Hospitals Private Limited | Managing Director | 27 Sep 2021 | 5 Years 1 Months | Current |
| Sobha Velamuru | Director | 27 Sep 2021 | 5 Years 1 Months | Current |
| Katakam Ushasree Also directs: Sai Siddartha Super Speciality Hospitals LLP | Director | 27 Sep 2021 | 5 Years 1 Months | Current |
| Puchalapalli Sankeerthi | Director | 27 Sep 2021 | 5 Years 1 Months | Current |
| Ramakrishna Reddy Madakala Also directs: Lungs Life Care LLP, Krishnasasi Property Holdings Private Limited, Krishnasasi Health Care Private Limited and 1 more | Director | 27 Sep 2021 | 5 Years 1 Months | Current |
Peer comparison
Usk Therapeutics Private Limited is compared with the 8 companies closest to it by revenue in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Allycure Lifesciences Private Limited | ₹2.22 Cr (FY 2025) | 116.0% | Indore, Madhya Pradesh, India | |||
| Mohini Biotech Private Limited | ₹2.22 Cr (FY 2019) | 1.0% | Mumbai, Maharashtra, India | |||
| Larsen Formulations Private Limited | ₹2.22 Cr (FY 2025) | 15.0% | Mumbai, Maharashtra, India | |||
| Chemosil Industries Private Limited | ₹2.22 Cr (FY 2024) | Pardi, Gujarat, India | ||||
| Usk Therapeutics Private Limitedthis company | ₹2.22 Cr (FY 2025) | -₹98.93 Lakh | -44.6% | 14.0% | 15 | Kadugodi, Karnataka, India |
| Chandra Drugs Private Limited | ₹2.22 Cr (FY 2024) | 31.0% | Indore, Madhya Pradesh, India | |||
| Ambey Chemtech Private Limited | ₹2.21 Cr (FY 2024) | 2106.0% | Meghnagar, Madhya Pradesh, India | |||
| Rajasthan Pesticides Limited | ₹2.21 Cr (FY 2021) | -24.0% | Jaipur, Rajasthan, India | |||
| Mendel Pharma Private Limited | ₹2.21 Cr (FY 2024) | 1.0% | Hyderabad, Telangana, India |
To see the full peer comparison of Usk Therapeutics Private Limited, buy the company report.
Auditor
Usk Therapeutics Private Limited is audited by MANI SAI & CO for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| MANI SAI & CO | FY 2023 | 018153S |
Shareholding
The shareholding of Usk Therapeutics Private Limited is on record for 2 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Usk Therapeutics Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Usk Therapeutics Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Usk Therapeutics Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Usk Therapeutics Private Limited has a workforce of 15 employees on its EPFO records as of Mar 2026, across 1 active EPFO establishment.
Employee count
15
Active EPFO establishments
1
Employee growth
-28.6%
Headcount by financial year
| Financial year | Employees (EPFO) |
|---|---|
| FY 2025-26 | 15 |
| FY 2024-25 | |
| FY 2023-24 |
To see the full employee and EPFO history of Usk Therapeutics Private Limited, buy the company report.
GST
Usk Therapeutics has 2 GST registrations: 2 active.
Total GSTINs
2
Active
2
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AACCU9281E1Z4 | Telangana | Active | 27 Oct 2021 |
| 37AACCU9281E1Z2 | Andhra Pradesh | Active | 06 Dec 2022 |
To see the full GST registrations and return filing status of Usk Therapeutics Private Limited, buy the company report.
Recent activity
Usk Therapeutics Private Limited has 5 board changes on record since 2021: 5 appointments. The latest: Katakam Ushasree was appointed as Director on 27 Sep 2021.
AGM
Usk Therapeutics Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Usk Therapeutics Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Bangalore.
Appointed
Katakam Ushasree was appointed as Director.
Appointed
Puchalapalli Sankeerthi was appointed as Director.
Appointed
Ramakrishna Reddy Madakala was appointed as Director.
Appointed
Sadu Kameswari was appointed as Managing Director.
Appointed
Sobha Velamuru was appointed as Director.
Incorporation
27 Sep 2021
Usk Therapeutics Private Limited was registered on 27 Sep 2021 with Roc Bangalore & aged 5 years 1 month as per MCA records.
Frequently asked questions
Usk Therapeutics is an active private limited company based in Kadugodi, Karnataka, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 27 September 2021 (5+ years old) and is registered under CIN U24290KA2021PTC152293.
Usk Therapeutics has 5 current directors:
- Sadu Kameswari - Managing Director
- Sobha Velamuru - Director
- Katakam Ushasree - Director
- Puchalapalli Sankeerthi - Director
- Ramakrishna Reddy Madakala - Director
The latest financial statements of Usk Therapeutics on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2022 are in the company report.
The GSTIN of Usk Therapeutics is 36AACCU9281E1Z4, registered in Telangana. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 37AACCU9281E1Z2 (Andhra Pradesh).
The CIN (Corporate Identification Number) of Usk Therapeutics is U24290KA2021PTC152293. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Usk Therapeutics was incorporated on 27 September 2021, making it 5+ years old. It is registered with the Registrar of Companies, Bangalore.
The peers of Usk Therapeutics by revenue are Allycure Lifesciences Private Limited, Mohini Biotech Private Limited, Larsen Formulations Private Limited, Chemosil Industries Private Limited, Chandra Drugs Private Limited and 3 more, all in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Katakam Ushasree was appointed as Director on 27 Sep 2021. Puchalapalli Sankeerthi was appointed as Director on 27 Sep 2021. Ramakrishna Reddy Madakala was appointed as Director on 27 Sep 2021. Usk Therapeutics has 5 board changes on record in total.
Yes, Usk Therapeutics is registered as a micro enterprise under Udyam registration (number: UDYAM-TS-20-0024034).
The registered office of Usk Therapeutics is at Flat No 102 1st Floor Sv Elegant Syno.21 & 27 Kumbena Agrahara Belathur, Kadugodi, Karnataka, India – 560067.
Usk Therapeutics operates in the pharma industry, in the drug formulation and development segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages